Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Zeria Licenses in Visicol from InKine
September 3, 2001
- World News in Brief
September 3, 2001
- IPLS to Focus on Changing Licensing Business -2-
September 3, 2001
- IPLS to Focus on Changing Licensing Business -1-
September 3, 2001
- Hospital Chains Will Increase: Ihoken
September 3, 2001
- Air Liquid Japan: Healthcare Accounts for 8% of Total Sales
September 3, 2001
- REGULATORY NEWS IN BRIEF
September 3, 2001
- Korosho Asks Bayer, Takeda to Take Safety Measures Regarding Cerivastatin
August 27, 2001
- Efco, Kyuyukai Postpone Merger to Next Fiscal Year
August 27, 2001
- Korosho to Listen to Industry's Opinions on Amending PAL
August 27, 2001
- Pharmacists Are Absent from 64% of Stores Selling Drugs at Night
August 27, 2001
- Price Adjustment Method No Longer Functions Properly: Mr Fujii, New Diet Member
August 27, 2001
- OCT NEWS IN BRIEF
August 27, 2001
- Economic Reform Should Not Affect Quality of Social Security Services: Mr Takemi, Lower House Member
August 27, 2001
- Yamanouchi Discovers Immunocompetent Cell Activating Gene
August 27, 2001
- Innovex to Establish Japan's 1st MR Syndicate Team Next Year: Mr Feldman
August 27, 2001
- Stage 2 Schedule Set for Quality Reevaluation of 249 Ingredients
August 27, 2001
- Genomic Analysis by Industry, Government, Academia Started
August 27, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -2-
August 27, 2001
- Launching of Tarivid Generics Postponed Due to Patent Problems
August 27, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…